查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
美国透析市场规模，按类型，按产品/服务，按最终用途，行业分析报告，增长潜力，适用性，竞争市场份额和预测，2023-2032
市场调查报告书
商品编码
1235067

美国透析市场规模，按类型，按产品/服务，按最终用途，行业分析报告，增长潜力，适用性，竞争市场份额和预测，2023-2032

U.S. Dialysis Market Size, By Type, By Product & Service, By End-use, Industry Analysis Report, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 330 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于与生活方式改变相关的糖尿病激增，美国的透析市场预计将在 2032 年之前显着增长。

慢性病的增加、美国透析领域的科学技术进步、人口老龄化以及家庭透析需求的增加是推动该行业发展的一些主要因素。 此外，可支配收入的增加和医疗保健成本的增加预计将改善美国透析行业的前景。

新兴市场参与者正在投资研发计划，以开发突破性技术来提高患者护理质量。 例如，2021 年 3 月，百特 (Baxter) 的 AK98（人工肾 98）透析机获得美国 FDA 批准。 该设备旨在用于离散超滤治疗以及急性或慢性液体超负荷和肾功能衰竭患者的间歇性血液透析。 预计这将进一步增加公司在市场上的影响力。

美国透析市场按类型、应用、最终用途和区域划分。

按类型划分，由于在医疗程序中越来越多地使用创新和技术先进的设备，腹膜透析预计将在预计的时间表内扩大。 此外，腹膜透析与血液透析相比有几个优点，例如饮食限制减少、生活方式选择自由以及需要经常去医院就诊。

由于对透析治疗作为肾臟疾病治疗的一部分的需求不断增长，到 2022 年，消耗品领域的销售额将超过 58 亿美元。 市场扩张是由确保有效治疗的导管等消耗品的开发推动的。 随着透析治疗的普及，对透析必需耗材的需求将增加，这有望刺激市场增长。

在最终用途方面，由于生活质量提高、差旅成本降低、灵活性和患者移动方便等好处，预计家庭透析在未来几年内将显着增长。

按区域划分，太平洋中央透析市场预计从 2023 年到 2032 年的复合年增长率将超过 3.5%。 这是由于该地区疾病负担高、私有化程度不断提高、医疗保险普及率不断提高、合格卫生人员数量不断增加以及人口老龄化、易患多种慢性病等背景下取得的快速进展。

内容

第 1 章研究方法和范围

第 2 章执行摘要

第 3 章美国透析行业洞察

  • 行业情况
  • 影响行业的因素
    • 司机
      • 终末期肾病 (ESRD) 患者增加
      • 糖尿病患病率增加
      • 缺乏供体肾臟
      • 可用于透析治疗的有利报销方案
      • 研发投资
    • 行业潜在的风险和挑战
      • 产品召回
      • 治疗并发症
  • 增长分析
    • 按类型
    • 按产品/服务
    • 按最终用途
  • COVID-19 影响分析
  • 监管状况
    • 美国
  • 赎回场景
  • 价值链分析
  • 未来的市场趋势
  • 技术概况
  • 波特分析
  • PESTEL 分析

第 4 章竞争格局，2022 年

  • 介绍
  • 公司矩阵分析，2022 年
  • 战略仪表板，2022 年

第 5 章美国透析市场：按类型列出

  • 主要类型趋势
  • 血液透析
  • 腹膜透析

第 6 章美国透析市场：按产品/服务分类

  • 主要产品和服务趋势
  • 设备
    • 透析器
    • 水处理设备
    • 其他
  • 消耗品
    • 透析器
    • 导管
    • 访问产品
    • 集中註意力
    • 其他
  • 服务内容
    • 急性透析
    • 慢性透析

第 7 章美国透析市场：按最终用途分类

  • 主要的最终用户趋势
  • 中心透析
  • 家庭透析

第 8 章美国透析市场：按区域列出

  • 主要区域的趋势
  • 中东北区
    • 伊利诺伊州
    • 印第安纳州
    • 密歇根
    • 俄亥俄州
    • 威斯康星州
  • 西南中区
    • 阿肯色州
    • 路易斯安那州
    • 俄克拉何马州
    • 得克萨斯州
  • 南大西洋区
    • 特拉华州
    • 佛罗里达州
    • 格鲁吉亚
    • 马里兰州
    • 北卡罗来纳州
    • 南卡罗来纳州
    • 弗吉尼亚
    • 西弗吉尼亚州
    • 华盛顿特区
  • 中东北区
    • 康涅狄格州
    • 主要
    • 马萨诸塞州
    • 新罕布什尔州
    • 罗德岛
    • 佛蒙特州
    • 新泽西州
    • 纽约
    • 宾夕法尼亚州
  • 东南中区
    • 阿拉巴马州
    • 肯塔基州
    • 密西西比州
    • 田纳西州
  • 西北中区
    • 爱荷华州
    • 堪萨斯州
    • 明尼苏达州
    • 密苏里州
    • 内布拉斯加州
    • 北达科他州
    • 南达科他州
  • 太平洋地区
    • 阿拉斯加
    • 加州
    • 夏威夷
    • 俄勒冈州
    • 华盛顿
  • 山区
    • 亚利桑那州
    • 科罗拉多州
    • 犹他州
    • 内华达州
    • 新墨西哥州
    • 爱达荷州
    • 蒙大拿州
    • 怀俄明州

第九章公司简介

  • Asahi Kasei Corporation
  • American Renal Associates
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • DaVita Inc.
  • Becton, Dickinson and Company
  • Fresenius Medical Care AG & Co.
  • Medtronic plc
  • Nipro Corporation
  • Sanderling Renal Services
  • Toray Industries Inc.
  • U.S. Renal Care, Inc.
简介目录
Product Code: 5091

The U.S. Dialysis Market is expected to grow considerably through 2032 owing to the surging prevalence of diabetes in the U.S. given a drastic change in lifestyle.

Growing incidences of chronic diseases, scientific and technical breakthroughs in dialysis in the United States, an aging population, as well as rising demand for at-home dialysis are some of the key factors expected to drive industry growth. Additionally, rising disposable income and higher healthcare costs are anticipated to improve the U.S. dialysis industry outlook.

Leading market players are investing in R&D initiatives to develop breakthrough technologies to improve the quality of patient care. For instance, in March 2021, Baxter received U.S. FDA approval in March 2021 for its AK98 (Artificial kidney 98) dialysis machine. The device is meant to be employed for intermittent hemodialysis as well as isolated ultrafiltration therapies for individuals with acute or chronic fluid overload or renal failure. The move is likely to bolster the company's prominence in the market.

The U.S. dialysis market has been divided in terms of type, application, end-use, and zone.

Based on type, peritoneal dialysis is anticipated to expand through the forecast timeline due to the increasing use of innovative and technically advanced devices during medical procedures. Moreover, peritoneal dialysis boasts of several benefits over hemodialysis, including fewer dietary restrictions, more freedom over lifestyle choices, and no need for frequent hospital visits.

With respect to application, the consumables segment held more than USD 5.8 billion in revenue in 2022 credited to the rising requirement for dialysis therapy as a form of kidney disease treatment. The market expansion is expedited by developments in consumables including catheters, which guarantee effective therapy. The use of dialysis therapy will increase demand for the supplies needed for the operation, fueling segmental growth.

In terms of end-use, the home dialysis segment is poised to grow significantly over the review years attributed to the several advantages it offers, including better quality of life, lower travel costs, flexibility, and simple patient mobility, leading to a rise in its adoption.

Based on zone, the Pacific Central dialysis market is speculated to grow at more than 3.5% CAGR from 2023 to 2032 driven by the massive disease burden in the region, rising privatization, rising health insurance penetration, aggravating efforts to increase the number of qualified health care personnel, and the rapidly aging population susceptible to several chronic illnesses.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 U.S. dialysis industry 360 degree synopsis, 2018-2032
    • 2.1.1 Business trends
    • 2.1.2 Type trends
    • 2.1.3 Product & service trends
    • 2.1.4 End-use trends
    • 2.1.5 Zonal trends

Chapter 3 US Dialysis Industry Insights

  • 3.1 Industry landscape
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
      • 3.2.1.2 Increasing incidence of diabetes
      • 3.2.1.3 Shortage of donor kidneys
      • 3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
      • 3.2.1.5 R&D investments
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Product recalls
      • 3.2.2.2 Complications in the treatment
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By product & services
    • 3.3.3 By end-use
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
  • 3.6 Reimbursement scenario
  • 3.7 Value chain analysis
  • 3.8 Future market trends
  • 3.9 Technology landscape
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Strategy dashboard, 2022

Chapter 5 US Dialysis Market, By Type

  • 5.1 Key type trends
  • 5.2 Hemodialysis
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Peritoneal Dialysis
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 US Dialysis Market, By Product and Services

  • 6.1 Key product and services trends
  • 6.2 Equipment
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.2 Dialysis machines
      • 6.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.3 Water treatment systems
      • 6.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.4 Others
      • 6.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Consumables
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.3.2 Dialyzers
      • 6.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.3.3 Catheters
      • 6.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.3.4 Access products
      • 6.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.3.5 Concentrates
      • 6.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.3.6 Others
      • 6.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Services
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.4.2 Acute dialysis
      • 6.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.4.3 Chronic dialysis
      • 6.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 US Dialysis Market, By End-use

  • 7.1 Key end-use trends
  • 7.2 In-center dialysis
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Home dialysis
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 US Dialysis Market, By Zone

  • 8.1 Key zonal trends
  • 8.2 East North Central
    • 8.2.1 Illinois
    • 8.2.2 Indiana
    • 8.2.3 Michigan
    • 8.2.4 Ohio
    • 8.2.5 Wisconsin
  • 8.3 West South Central
    • 8.3.1 Arkansas
    • 8.3.2 Louisiana
    • 8.3.3 Oklahoma
    • 8.3.4 Texas
  • 8.4 South Atlantic
    • 8.4.1 Delaware
    • 8.4.2 Florida
    • 8.4.3 Georgia
    • 8.4.4 Maryland
    • 8.4.5 North Carolina
    • 8.4.6 South Carolina
    • 8.4.7 Virginia
    • 8.4.8 West Virginia
    • 8.4.9 Washington, D.C.
  • 8.5 North East
    • 8.5.1 Connecticut
    • 8.5.2 Maine
    • 8.5.3 Massachusetts
    • 8.5.4 New Hampshire
    • 8.5.5 Rhode Island
    • 8.5.6 Vermont
    • 8.5.7 New Jersey
    • 8.5.8 New York
    • 8.5.9 Pennsylvania
  • 8.6 East South Central
    • 8.6.1 Alabama
    • 8.6.2 Kentucky
    • 8.6.3 Mississippi
    • 8.6.4 Tennessee
  • 8.7 West North Central
    • 8.7.1 Iowa
    • 8.7.2 Kansas
    • 8.7.3 Minnesota
    • 8.7.4 Missouri
    • 8.7.5 Nebraska
    • 8.7.6 North Dakota
    • 8.7.7 South Dakota
  • 8.8 Pacific Central
    • 8.8.1 Alaska
    • 8.8.2 California
    • 8.8.3 Hawaii
    • 8.8.4 Oregon
    • 8.8.5 Washington
  • 8.9 Mountain States
    • 8.9.1 Arizona
    • 8.9.2 Colorado
    • 8.9.3 Utah
    • 8.9.4 Nevada
    • 8.9.5 New Mexico
    • 8.9.6 Idaho
    • 8.9.7 Montana
    • 8.9.8 Wyoming

Chapter 9 Company Profiles

  • 9.1 Asahi Kasei Corporation
  • 9.2 American Renal Associates
  • 9.3 B. Braun Melsungen AG
  • 9.4 Baxter International Inc.
  • 9.5 DaVita Inc.
  • 9.6 Becton, Dickinson and Company
  • 9.7 Fresenius Medical Care AG & Co.
  • 9.8 Medtronic plc
  • 9.9 Nipro Corporation
  • 9.10 Sanderling Renal Services
  • 9.11 Toray Industries Inc.
  • 9.12 U.S. Renal Care, Inc.